U.S. Physical Therapy, Inc. (USPH) is a Healthcare stock trading at $74.59 (as of 2026-07-24), with a market capitalization of $1.14B and a trailing P/E of 32.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics that provide rehabilitation and related care for orthopedic conditions, sports injuries, and other therapeutic needs, including pre- and post-operative treatment. It reports two segments—clinic operations and industrial injury prevention services—serving employers such as Fortune 500 companies, as well as insurers and their contractors.
U.S. Physical Therapy operates outpatient physical therapy clinics and provides industrial injury prevention services, it makes money by delivering patient care and related injury prevention programs through its clinic network and services.
Outpatient clinic revenue is fundamentally driven by how many patient visits each owned or managed clinic delivers per day, and by how quickly the company adds new clinics.
| Physical Therapy Ops | $0.2B |
| Industrial Injury Prevention | $0.1B |
Business quality (Mixed): The business is split into two reportable lines (clinic care, and industrial injury prevention), and the operating KPIs that appear most directly connected to that model are trackable (daily visits and clinic additions). Key sensitivities include payer mix, especially workers' compensation, and period-to-period visit disruption (such as weather).
Valuation: At 124× earnings, USPH trades 395% above the Healthcare Services average (25×). Note: one-time items can distort reported P/E.
| Price | $74.59 |
| Market Cap | $1.14B |
| P/E Ratio | 32.7 |
| EV / EBITDA | 12.9 |
| Price / Book | 2.42 |
| Price / Sales | 1.43 |
| FCF Yield | 5.9% |
| DCF Value (model) | $54.43 |
| DCF Upside vs Price | -27.0% |
| Revenue (TTM) | $780.99M |
| Net Margin | 5.1% |
| Revenue Growth (YoY) | 7.9% |
| EPS Growth (YoY) | -115.0% |
| FCF Growth (YoY) | -78.4% |
| Altman Z-Score | 2.08 (grey) |
| Stock P/E | 32.7 |
| Sector P/E (Healthcare) | 21.2 |
| Industry P/E (Healthcare Services) | 27.9 |
| vs Sector | 54.0% |
| vs Industry | 17.4% |
| Top Institutional Holder | BlackRock, Inc. ($165.55M) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 6 |
| Sector | Healthcare |
| Industry | Healthcare Services |
| CEO | Christopher J. Reading |
| Employees | 4,034 |
| Country | US |
| IPO Date | 1992-05-29 |
Data as of 2026-07-24.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.